Presuming the BusinessInsider.com report is correct, then CureVac's stock may bounce around in the current trading range. As we get closer to the August EMA meeting, I'd expect the stock to move higher again in anticipation of approval.
This post is for paying subscribers only
You might also like...
New Buy! Takeoff for Airline Stocks?
3 min read
Cutting Losses on These Stocks
2 min read
Adding to this "Essential" Holding + Covering Shorts